These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25249975)

  • 1. APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment.
    Dixon RA; DeCarlo CA; MacDonald SW; Vergote D; Jhamandas J; Westaway D
    Front Aging Neurosci; 2014; 6():236. PubMed ID: 25249975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Health and Genetic Risk Affect Mild Cognitive Impairment Status and 4-Year Stability: Evidence From the Victoria Longitudinal Study.
    DeCarlo CA; MacDonald SW; Vergote D; Jhamandas J; Westaway D; Dixon RA
    J Gerontol B Psychol Sci Soc Sci; 2016 Nov; 71(6):1004-1014. PubMed ID: 26362601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients.
    Lanni C; Garbin G; Lisa A; Biundo F; Ranzenigo A; Sinforiani E; Cuzzoni G; Govoni S; Ranzani GN; Racchi M
    J Alzheimers Dis; 2012; 32(4):919-26. PubMed ID: 22890094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.
    Martínez MF; Martín XE; Alcelay LG; Flores JC; Valiente JM; Juanbeltz BI; Beldarraín MA; López JM; Gonzalez-Fernández MC; Salazar AM; Gandarias RB; Borda SI; Marqués NO; Amillano MB; Zabaleta MC; de Pancorbo MM
    BMC Neurosci; 2009 Sep; 10():125. PubMed ID: 19793392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment is associated with selected functional markers: integrating concurrent, longitudinal, and stability effects.
    Dolcos S; MacDonald SWS; Braslavsky A; Camicioli R; Dixon RA
    Neuropsychology; 2012 Mar; 26(2):209-223. PubMed ID: 22251311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.
    Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Kenney AE; Gross CJ; Taub ES; Plassman BL; Fisher GG
    Neuropsychology; 2013 Jan; 27(1):86-94. PubMed ID: 23356599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between ApoE ε4 Carrier Status and Cardiovascular Risk Factors on Mild Cognitive Impairment among Mexican Older Adults.
    Aguilar-Navarro SG; Gonzalez-Aparicio II; Avila-Funes JA; Juárez-Cedillo T; Tusié-Luna T; Mimenza-Alvarado AJ
    Brain Sci; 2021 Jan; 11(1):. PubMed ID: 33430178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of CSF Neurogranin and
    Fan Y; Gao Y; Therriault J; Luo J; Ba M; Zhang H;
    Front Aging Neurosci; 2021; 13():667899. PubMed ID: 33986657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
    Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
    Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoE alleles and tau markers in patients with different levels of cognitive impairment.
    Lavados M; Farías G; Rothhammer F; Guillon M; Mujica MC; Maccioni C; Maccioni RB
    Arch Med Res; 2005; 36(5):474-9. PubMed ID: 16099324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
    Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
    JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation of ApoE and COMT gene-gene interactions to cognitive and motor function in community-dwelling older adults: a pilot study.
    Pizzonia KL; Suhr JA; Clark LA; Clark BC
    Front Aging Neurosci; 2023; 15():1206473. PubMed ID: 37744392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Analysis of Polymorphisms in
    Wu Y; Yin J; Yang B; Tang L; Feng W; Liu X; Zhao X; Cheng Z
    Neuropsychiatr Dis Treat; 2021; 17():1125-1133. PubMed ID: 33907405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
    Shen S; Zhou W; Chen X; Zhang J;
    Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between APOE polymorphisms and seven diseases with cognitive impairment including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies in southeast China.
    Chen KL; Sun YM; Zhou Y; Zhao QH; Ding D; Guo QH
    Psychiatr Genet; 2016 Jun; 26(3):124-31. PubMed ID: 26981880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBQ-8i polymorphism is not an independent risk factor for mild cognitive impairment and Alzheimer's disease in APOE-4 carriers.
    Martin XE; Martinez MF; Fernandez DG; Busto FG; Alcelay LG; Ferreras MJC; Flores JC; Pancorbo MM
    Curr Alzheimer Res; 2012 May; 9(4):467-72. PubMed ID: 22272618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.